News Daily News Little Pre- and Postmarket Testing for Most Recalled CV Devices Michael O'Riordan September 16, 2024
News Daily News FDA to Add New Diversity Requirements for Certain Clinical Studies Todd Neale July 15, 2024
News Daily News Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective Michael O'Riordan February 23, 2024
News Conference News ISC 2024 AI-Based System Boosts Quality of Stroke Care and Reduces Events Todd Neale February 16, 2024